Change Location
Set Price Drop Alert for:
TRIFLUOPERAZINE HCL
- QTY 90
- 2 MG
- Tablet
More Ways to Save On:
TRIFLUOPERAZINE HCL
- QTY 90
- 2 MG
- Tablet
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
TRIFLUOPERAZINE HCL Lifestyle Interactions
-
Fluconazole 200mg/100mL, Sodium Chloride 0.9%, Solution for injection
• Interaction: Caffeine-containing Foods/Beverages• Severity: Moderate• Notes for Consumers: Although an interaction is possible, these drugs are often used together. Side effects from Caffeine may get worse if you take Fluconazole. Too much Caffeine can cause effects like nausea, nervousness, or sleeplessness. You may need to limit your Caffeine intake. Common foods and beverages containing caffeine include coffee, teas, colas and chocolate. Many non-prescription drugs and diet aids may also contain caffeine.• Notes for Professionals: Fluconazole has been shown to inhibit the clearance of caffeine by 25 percent. The clinical significance of these interactions has not been determined. -
Fluconazole 200mg/100mL, Sodium Chloride 0.9%, Solution for injection
• Interaction: Marijuana• Severity: Moderate• Notes for Consumers: The effects of marijuana may be increased and side effects may get worse if it is combined with this medicine. Do not drive or operate machinery until you know how this combination will affect you. Contact your health care provider right away if you notice slurred speech, confusion, severe drowsiness, increased heart rate, or any other new or unusual side effects.• Notes for Professionals: The incidence of marijuana associated adverse effects may change following coadministration with fluconazole. Fluconazole is an inhibitor of CYP2C9 and CYP3A4, two isoenzymes responsible for the metabolism of marijuana's most psychoactive compound, delta-9-tetrahydrocannabinol (Delta-9-THC). When given concurrently with fluconazole the amount of Delta-9-THC converted to the active metabolite 11-hydroxy-delta-9-tetrahydrocannabinol (11-OH-THC) may be reduced. These changes in Delta-9-THC and 11-OH-THC plasma concentrations may result in an altered marijuana adverse event profile.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.